Correlation Between Kiniksa Pharmaceuticals and Ventyx Biosciences
Can any of the company-specific risk be diversified away by investing in both Kiniksa Pharmaceuticals and Ventyx Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kiniksa Pharmaceuticals and Ventyx Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kiniksa Pharmaceuticals and Ventyx Biosciences, you can compare the effects of market volatilities on Kiniksa Pharmaceuticals and Ventyx Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kiniksa Pharmaceuticals with a short position of Ventyx Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kiniksa Pharmaceuticals and Ventyx Biosciences.
Diversification Opportunities for Kiniksa Pharmaceuticals and Ventyx Biosciences
0.2 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Kiniksa and Ventyx is 0.2. Overlapping area represents the amount of risk that can be diversified away by holding Kiniksa Pharmaceuticals and Ventyx Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ventyx Biosciences and Kiniksa Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kiniksa Pharmaceuticals are associated (or correlated) with Ventyx Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ventyx Biosciences has no effect on the direction of Kiniksa Pharmaceuticals i.e., Kiniksa Pharmaceuticals and Ventyx Biosciences go up and down completely randomly.
Pair Corralation between Kiniksa Pharmaceuticals and Ventyx Biosciences
Given the investment horizon of 90 days Kiniksa Pharmaceuticals is expected to generate 3.76 times less return on investment than Ventyx Biosciences. But when comparing it to its historical volatility, Kiniksa Pharmaceuticals is 2.92 times less risky than Ventyx Biosciences. It trades about 0.03 of its potential returns per unit of risk. Ventyx Biosciences is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 222.00 in Ventyx Biosciences on November 3, 2024 and sell it today you would lose (21.00) from holding Ventyx Biosciences or give up 9.46% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 99.6% |
| Values | Daily Returns |
Kiniksa Pharmaceuticals vs. Ventyx Biosciences
Performance |
| Timeline |
| Kiniksa Pharmaceuticals |
| Ventyx Biosciences |
Kiniksa Pharmaceuticals and Ventyx Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Kiniksa Pharmaceuticals and Ventyx Biosciences
The main advantage of trading using opposite Kiniksa Pharmaceuticals and Ventyx Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kiniksa Pharmaceuticals position performs unexpectedly, Ventyx Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ventyx Biosciences will offset losses from the drop in Ventyx Biosciences' long position.| Kiniksa Pharmaceuticals vs. Nuvalent | Kiniksa Pharmaceuticals vs. Ventyx Biosciences | Kiniksa Pharmaceuticals vs. Arcellx | Kiniksa Pharmaceuticals vs. Cullinan Oncology LLC |
| Ventyx Biosciences vs. Arcellx | Ventyx Biosciences vs. Immunocore Holdings | Ventyx Biosciences vs. Vaxcyte | Ventyx Biosciences vs. Nuvalent |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |